Clinical Trial Update: In UTERO Treatment of Cytomegalovirus Congenital Infection With Valacyclovir [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating in utero treatment of congenital cytomegalovirus infection with valacyclovir was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Cytomegalovirus Infection

Drugs mentioned

• Valacyclovir (Valacyclovir)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Viral Disease, Cytomegalovirus Infection | Phase 4 | Status: TERMINATED